These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8787547)

  • 21. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.
    Russell CB; Rand H; Bigler J; Kerkof K; Timour M; Bautista E; Krueger JG; Salinger DH; Welcher AA; Martin DA
    J Immunol; 2014 Apr; 192(8):3828-36. PubMed ID: 24646743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12.
    Kaye RE; Fruman DA; Bierer BE; Albers MW; Zydowsky LD; Ho SI; Jin YJ; Castells MC; Schreiber SL; Walsh CT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8542-6. PubMed ID: 1382293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?
    Rückert R; Asadullah K; Seifert M; Budagian VM; Arnold R; Trombotto C; Paus R; Bulfone-Paus S
    J Immunol; 2000 Aug; 165(4):2240-50. PubMed ID: 10925312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes.
    Müschen A; Mirmohammadsadegh A; Jarzebska-Deussen B; Abts HF; Ruzicka T; Michel G
    Inflamm Res; 1999 Oct; 48(10):539-43. PubMed ID: 10563471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
    Rolfe FG; Valentine JE; Sewell WA
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
    Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
    Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes.
    Kis K; Bodai L; Polyanka H; Eder K; Pivarcsi A; Duda E; Soos G; Bata-Csorgo Z; Kemeny L
    Int Immunopharmacol; 2006 Mar; 6(3):358-68. PubMed ID: 16428071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
    Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p53 protein in psoriasis.
    Baran W; Szepietowski JC; Szybejko-Machaj G
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):79-83. PubMed ID: 16200332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts.
    Aomatsu T; Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Yoden A; Tamai H; Fujiyama Y; Andoh A
    Int J Mol Med; 2012 Nov; 30(5):1152-8. PubMed ID: 22895606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1.
    Almawi WY; Assi JW; Chudzik DM; Jaoude MM; Rieder MJ
    Cell Transplant; 2001; 10(7):615-23. PubMed ID: 11714196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G
    J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53 protein before and after PUVA treatment in psoriasis.
    Hannuksela-Svahn A; Pääkkö P; Autio P; Reunala T; Karvonen J; Vähäkangas K
    Acta Derm Venereol; 1999 May; 79(3):195-9. PubMed ID: 10384915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
    Kjellerup RB; Johansen C; Kragballe K; Iversen L
    Br J Dermatol; 2013 Feb; 168(2):339-45. PubMed ID: 22924482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
    Rømer J; Hasselager E; Nørby PL; Steiniche T; Thorn Clausen J; Kragballe K
    J Invest Dermatol; 2003 Dec; 121(6):1306-11. PubMed ID: 14675174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel steroid derivative modulates gene expression of cytokines and growth regulators.
    Michel G; Nowok K; Beetz A; Ried C; Kemény L; Ruzicka T
    Skin Pharmacol; 1995; 8(5):215-20. PubMed ID: 8527152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells.
    Murakami R; Kambe F; Mitsuyama H; Okumura K; Murohara T; Niwata S; Yamamoto R; Seo H
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2034-40. PubMed ID: 12958044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses.
    Homey B; Assmann T; Vohr HW; Ulrich P; Lauerma AI; Ruzicka T; Lehmann P; Schuppe HC
    J Immunol; 1998 Jun; 160(11):5331-40. PubMed ID: 9605132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.